CDK Global Overview
Latest ROE for CDK Global: 57.97% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow57.97%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CDK is 57.97%. That is above the Technology sector average of 48.11%. Investors often review this figure alongside CDK Global's historical trend and sector peers before judging valuation or financial health.
Against Technology companies, CDK currently prints 57.97% for ROE, while the sector average sits near 48.11%. That is roughly 20.5% above the sector mean. Large gaps often invite a closer look at CDK Global's growth, margins, and balance sheet.
Return on Equity shows how effectively CDK Global converts resources into returns. At 57.97%, CDK may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CDK's ROE (57.97%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack CDK Global's ROE against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.
